A study in humans demonstrated that the mir-486 was significantly upregulated in serum from patients with mild traumatic brain injury at baseline compared to controls, with expression progressively reducing at 24 and 48 hours post-injury, identifying it as a sensitive and specific biomarker for monitoring the post-trauma period [Polito et al. DOI:10.1007/s11033-020-05386-7]. In a separate forensic investigation, exosomal the mir-486 was significantly elevated in postmortem plasma-derived exosomes from individuals with high-grade coronary atherosclerosis, highlighting its potential as a predictive biomarker for coronary atherosclerosis progression in postmortem diagnostics [Kim et al. DOI:10.3390/ijms25179619]. Another study in humans established that the mir-486 is the second most abundant miRNA in blood and bloodstains, with expression stable under normal storage for up to five months and at 37°C, though it was significantly down-regulated by freeze-thaw cycles and oxidant treatment [Fang et al. DOI:10.1016/j.fsigen.2018.10.001].